Dr Falk Pharma Australia was recently established to provide the Falk organisation with its own presence in Australia. Our parent company, Dr Falk Pharma GmbH is an independent family firm based in Freiburg, Germany. Guided by the Falk philosophy, Dr Falk Pharma Australia is dedicated to improving patient outcomes through advancing the understanding and treatment of GI and Liver diseases. We seek to advance the understanding of these distressing and difficult to manage diseases through our support for a wide range of scientifically independent educational initiatives designed to meet the needs of healthcare professionals and patients. We are driven to distinguish ourselves from traditional ‘Big Pharma’ by treating our people as individuals with unique worth and our customers as partners. Our investments are targeted at improving the patient/HCP experience. We value true innovation and challenge ourselves to try new and exciting solutions for our customers. Within the treatment of GI and liver diseases, our goal is to develop innovative medicines with patient-friendly delivery mechanisms which relieve symptoms and encourage adherence to treatment.
